These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7749895)

  • 1. Pathology of multiple sclerosis: some new developments.
    Richardson EP
    Clin Neurosci; 1994; 2(3-4):253-7. PubMed ID: 7749895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
    Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
    Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathology of multiple sclerosis.
    Sobel RA
    Neurol Clin; 1995 Feb; 13(1):1-21. PubMed ID: 7739499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in the histopathology of MS?
    Kuhlmann T; Goldschmidt T; Antel J; Wegner C; König F; Metz I; Brück W
    J Neurol Sci; 2009 Nov; 286(1-2):86-91. PubMed ID: 19674757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodendrocytes in the early course of multiple sclerosis.
    Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
    Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blood-brain barrier (BBB) permeability in multiple sclerosis.
    Rafałowska J; Krajewski S; Dolińska E
    Neuropatol Pol; 1990; 28(1-2):41-54. PubMed ID: 2097537
    [No Abstract]   [Full Text] [Related]  

  • 7. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
    Johnson AJ; Suidan GL; McDole J; Pirko I
    Int Rev Neurobiol; 2007; 79():73-97. PubMed ID: 17531838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H
    Verh Dtsch Ges Pathol; 1996; 80():109-15. PubMed ID: 9064993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice.
    Onuki M; Ayers MM; Bernard CC; Orian JM
    Microsc Res Tech; 2001 Mar; 52(6):731-9. PubMed ID: 11276125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid precursor protein (APP) expression in multiple sclerosis lesions.
    Gehrmann J; Banati RB; Cuzner ML; Kreutzberg GW; Newcombe J
    Glia; 1995 Oct; 15(2):141-51. PubMed ID: 8567065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal damage in multiple sclerosis: a complex issue in a complex disease.
    Grigoriadis N; Ben-Hur T; Karussis D; Milonas I
    Clin Neurol Neurosurg; 2004 Jun; 106(3):211-7. PubMed ID: 15177770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remyelination capacity of the MS brain decreases with disease chronicity.
    Goldschmidt T; Antel J; König FB; Brück W; Kuhlmann T
    Neurology; 2009 Jun; 72(22):1914-21. PubMed ID: 19487649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination.
    Miller DJ; Rodriguez M
    Microsc Res Tech; 1995 Oct; 32(3):230-45. PubMed ID: 8527857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
    Kooi EJ; Geurts JJ; van Horssen J; Bø L; van der Valk P
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):1021-8. PubMed ID: 19680141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
    Musse AA; Harauz G
    Int Rev Neurobiol; 2007; 79():149-72. PubMed ID: 17531841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination.
    Wilczak N; Chesik D; Hoekstra D; De Keyser J
    Neurochem Int; 2008 Jun; 52(8):1431-5. PubMed ID: 18471934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis.
    Carlson NG; Hill KE; Tsunoda I; Fujinami RS; Rose JW
    J Neuroimmunol; 2006 May; 174(1-2):21-31. PubMed ID: 16516308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
    Wolswijk G; Balesar R
    Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.
    Bö L; Geurts JJ; van der Valk P; Polman C; Barkhof F
    Arch Neurol; 2007 Jan; 64(1):76-80. PubMed ID: 17210812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.